Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 745,314 | 636,427 | 462,779 | 355,909 | 363,545 |
| Cost of Goods | 162,289 | 151,475 | 121,515 | 97,416 | 94,921 |
| Gross Profit | 583,025 | 484,952 | 341,264 | 258,493 | 268,624 |
| Operating Expenses | 343,243 | 256,845 | 303,915 | 275,400 | 214,870 |
| Operating Income | 240,071 | 228,582 | 37,864 | -16,491 | 54,675 |
| Interest Expense | 11,516 | 12,185 | 18,571 | 17,344 | 17,098 |
| Other Income | 994 | -14,638 | -16,339 | 1,218 | -693 |
| Pre-tax Income | 229,549 | 201,759 | 2,954 | -32,617 | 36,884 |
| Income Tax | 38,992 | -91,081 | 82,964 | -19,026 | -555,885 |
| Net Income Continuous | 190,557 | 292,840 | -80,010 | -13,591 | 592,769 |
| Net Income | $190,557 | $292,840 | $-80,010 | $-13,591 | $592,769 |
| EPS Basic Total Ops | 1.02 | 1.38 | -0.42 | -0.07 | 3.25 |
| EPS Basic Continuous Ops | 1.02 | 1.38 | -0.42 | -0.07 | 3.25 |
| EPS Diluted Total Ops | 0.99 | 1.31 | -0.42 | -0.07 | 3.03 |
| EPS Diluted Continuous Ops | 0.99 | 1.31 | -0.42 | -0.07 | 2.92 |
| EBITDA(a) | $310,231 | $300,300 | $116,767 | $54,819 | $120,029 |